EUCTR2004-000631-28-IT进行中（未招募）不适用
Bosentan use in interstitial lung disease (open label). Long-term open-label study in patients with interstitial lung disease associated with systemic sclerosis who completed the protocol AC-052-330/BUILD 2.
ACTELION PHARMACEUTICALS ITALIA0 个研究点开始时间: 2004年9月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
Unknown
4 期
Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyIdiopathic Pulmonary FibrosisPulmonary HypertensionNonspecific Interstitial PneumoniaInterstitial Lung DiseaseNCT00637065Royal Brompton & Harefield NHS Foundation Trust48
进行中（未招募）
1 期
BOsentan for Mild Pulmonary vascular disease in Asd patients (the BOMPA trial): a double-blind, randomized controlled, pilot trial - BOMPA trialEUCTR2010-020209-33-BEniversity Hospitals Leuven20
已完成
不适用
The COLDICE Trial: Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease allianCERespiratory - Other respiratory disorders / diseasesInterstitial Lung DiseaseACTRN12615000718549auren Troy65
招募中
不适用
Pulmonary involvement (interstitial lung disease of known etiology) in patients with Seropositive and ACPA positive Rheumatoid Arthritis (RA-ILD I and II)Early detection of lung involvement in RAM05.9M05.1J99.0Seropositive rheumatoid arthritis, unspecifiedRheumatoid lung diseaseDRKS00028871Boehringer Ingelheim Pharma GmbH & Co. KG200
终止
4 期
Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)HypertensionNCT00120380Hannover Medical School40